1. Home
  2. COR

COR

Cencora Inc.

Logo Cencora Inc.

Health Care

Other Pharmaceuticals

Nasdaq

as 04-23-2024 4:00pm EST

$
-
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Founded: 2001 Country:
United States
United States
Employees: N/A City: CONSHOHOCKEN
Market Cap: 47.4B IPO Year: N/A
Target Price: $235.00 AVG Volume (30 days): 1.3M
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: 0.86% Dividend Payout Frequency: Quarterly
EPS: 9.19 EPS Growth: 11.39
52 Week Low/High: $163.37 - $246.75 Next Earning Date: 05-01-2024
Revenue: $271,579,412,000 Revenue Growth: 12.31%
Revenue Growth (this year): 12.47% Revenue Growth (next year): 6.38%

Share on Social Networks:

Stock Insider Trading Activity of Cencora Inc. (COR)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Clark Gina COR Executive Vice President Feb 13 '24 Sell $230.48 1,100 $253,528.00 24,802 SEC Form 4
Krikorian Lazarus COR SVP & Chief Accounting Officer Dec 1 '23 Sell $203.60 2,000 $407,204.00 19,876 SEC Form 4